InfuSystem reports record Q3 revenue $27.3M; net income turns positive; FY guidance at low end

InfuSystem Holdings, Inc

2022-Q3 EPS reported $0.00 revenue$81,084,000

Record Q3 net revenue $27.3M (+3% YoY); ITS segment revenue record $17.4M (+5% YoY).
Net income $0.4M ($0.02/diluted) vs net loss $0.4M in prior-year quarter; operating income up $1.3M to $0.9M.
Gross margin improved 200 bps to 59.5%; ITS gross margin 65.6%, DME 48.7%.
FY2022 guidance: revenue ~$112M (low end of prior 10-13% growth); Adj. EBITDA ~$22M (19-20% margin).
Nov 3: formed wound therapy partnership with Sanara MedTech and signed distribution agreement with Cork Medical.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

InfuSystem Holdings, Inc reported the third quarter ended September 30, 2022 results: revenue $27.3 million, net income $0.4 million, EPS $0.02 per diluted share.

Period: the third quarter ended September 30, 2022
Revenue: $27.3 million
Net income: $0.4 million
EPS: $0.02 per diluted share
Result: reported results

Exact text from the filing

• Net revenues totaled $27.3 million, an increase of 3% vs. prior year. ◦ Integrated Therapy Services ("ITS") net revenue was $17.4 million, an increase of 5% vs. prior year. ◦ Durable Medical Equipment Services ("DME Services") net revenue was $9.9 million, a decrease of 1% vs. prior year. • Gross profit was $16.2 million, an increase of 6% vs. prior year. • Gross margin was 59.5%, an increase of 2.0% vs. prior year. ◦ ITS gross margin was 65.6%, an increase of 1.8% vs. prior year. ◦ DME Services gross margin was 48.7%, an increase of 1.7% vs. prior year. • Operating income increased $1.3 million to $0.9 million vs. prior year. • Net income of $0.4 million, or $0.02 per diluted share, an increase of $0.9 million vs. prior year.

View on SEC.gov

47 earnings releases filed in the last 30 days. Browse all earnings releases →

InfuSystem Holdings, Inc filing history →

Source: SEC EDGAR

accession 0001628280-22-028748

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.